Company Filing History:
Years Active: 1998
Title: Maja Krajinovic: Pioneering Cancer Detection through Innovative DNA Markers
Introduction
Maja Krajinovic, a notable inventor based in Montreal, Canada, has made significant strides in the field of cancer diagnostics. Her groundbreaking research focuses on identifying tumor cells that express a mutator phenotype, which is crucial for improving cancer detection and treatment.
Latest Patents
Maja holds a patent for her innovative method titled "DNA markers to detect cancer cells expressing a mutator phenotype." This invention provides a comprehensive approach to diagnosing or predicting the prognosis of tumor cells in patients displaying a mutator phenotype. The method includes crucial steps such as obtaining genomic DNA samples from both tumor and non-tumor tissues, amplification of those samples using specific primers, and analyzing the resulting DNA variations that indicate genomic instability associated with mutator phenotypes.
Career Highlights
Maja Krajinovic is affiliated with the Centre de Recherche de l'Hôpital Sainte-Justine, where she has been actively involved in advancing cancer research. Her dedication to improving diagnostic methods has significantly impacted the landscape of cancer prognosis, offering new hope for patients and healthcare professionals alike.
Collaborations
Throughout her career, Maja has collaborated with esteemed colleagues such as Daniel Sinnett and Damian LaBuda. These partnerships have fostered a dynamic research environment, enabling innovative approaches to cancer diagnostics and enhancing the overall effectiveness of their findings.
Conclusion
Maja Krajinovic's contributions to the field of tumor detection through her patented methods demonstrate her commitment to innovation in cancer research. With her expertise and collaborative spirit, she continues to pave the way for advancements that could ultimately lead to more effective cancer treatments and improved patient outcomes.